The Motley Fool··Cory RenauerVir Biotech CEO Offloads $664K in Shares Amid Positive Clinical Pipeline
Vir Biotechnology CEO Marianne De Backer sold 72,559 shares worth $664,350, representing 6.76% of holdings. Sale aligns with historical patterns amid company's positive momentum.
VIRALPMYbiotechclinical trial results